Single-nucleotide polymorphism PCR for the detection of Mycoplasma pneumoniae and determination of macrolide resistance in respiratory samples

Journal of Microbiological Methods

Volumn 102, Issue , 2014, Pages 32-36

  Ji, Misuk ^a   Lee, Nam Sihk ^b   Oh, Ji Min ^b   Jo, Ji Yoon ^b   Choi, Eun Hwa ^c   Yoo, Soo Jin ^d   Kim, Hyo Bin ^d   Hwang, Sang Hyun ^e   Choi, Sang Ho ^a   Lee, Sang Oh ^a   Kim, Mi Na ^a   Sung, Heungsup ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Solgent Co Ltd   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e Hematologic Oncology Clinic   (South Korea)

Author keywords

23S rRNA gene; Macrolide resistance; Mutation; Mycoplasma pneumoniae; Single nucleotide polymorphism PCR

Indexed keywords

MACROLIDE; RNA 23S; ANTIINFECTIVE AGENT; BACTERIAL DNA; PRIMER DNA; RIBOSOME DNA;

AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOPLASMA PNEUMONIAE; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; RNA GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM; ADULT; CHILD; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMONIA, MYCOPLASMA; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, RIBOSOMAL, 23S; YOUNG ADULT;

EID: 84900835031     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2014.04.009     Document Type: Article

References (20)

1. Bebear C., Pereyre S., Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol 2011, 6:423-431.
2. Cao B., Zhao C.J., Yin Y.D., Zhao F., Song S.F., Bai L., Zhang J.Z., Liu Y.M., Zhang Y.Y., Wang H., Wang C. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin. Infect. Dis. 2010, 51:189-194.
3. Daxboeck F., Krause R., Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin. Microbiol. Infect. 2003, 9:263-273.
4. Li S.L., Sun H.M., Zhao H.Q., Cao L., Yuan Y., Feng Y.L., Xue G.H. A single tube modified allele-specific-PCR for rapid detection of erythromycin-resistant Mycoplasma pneumoniae in Beijing. Chin. Med. J. (Engl.) 2012, 125:2671-2676.
5. Liu Y., Ye X., Zhang H., Xu X., Li W., Zhu D., Wang M. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob. Agents Chemother. 2009, 53:2160-2162.
6. Liu Y., Ye X., Zhang H., Xu X., Li W., Zhu D., Wang M. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn. Microbiol. Infect. Dis. 2010, 67:355-358.
7. Matsubara K., Morozumi M., Okada T., Matsushima T., Komiyama O., Shoji M., Ebihara T., Ubukata K., Sato Y., Akita H., Sunakawa K., Iwata S. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J. Infect. Chemother. 2009, 15:380-383.
8. Matsuoka M., Narita M., Okazaki N., Ohya H., Yamazaki T., Ouchi K., Suzuki I., Andoh T., Kenri T., Sasaki Y., Horino A., Shintani M., Arakawa Y., Sasaki T. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother. 2004, 48:4624-4630.
9. Morozumi M., Iwata S., Hasegawa K., Chiba N., Takayanagi R., Matsubara K., Nakayama E., Sunakawa K., Ubukata K. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob. Agents Chemother. 2008, 52:348-350. Acute Respiratory Diseases Study Group.
10. Morozumi M., Takahashi T., Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother. 2010, 16:78-86.
11. Oh C.E., Choi E.H., Lee H.J. Detection of genetic mutations associated with macrolide resistance of Mycoplasma pneumoniae. Korean J. Pediatr. 2010, 53:178-183.
12. Peuchant O., Ménard A., Renaudin H., Morozumi M., Ubukata K., Bébéar C.M., Pereyre S. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J. Antimicrob. Chemother. 2009, 64:52-58.
13. Spuesens E.B., Hoogenboezem T., Sluijter M., Hartwig N.G., van Rossum A.M., Vink C. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J. Microbiol. Methods 2010, 82:214-222.
14. Spuesens E.B., Meijer A., Bierschenk D., Hoogenboezem T., Donker G.A., Hartwig N.G., Koopmans M.P., Vink C., van Rossum A.M. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J. Clin. Microbiol. 2012, 50:1999-2004.
15. Suzuki S., Yamazaki T., Narita M., Okazaki N., Suzuki I., Andoh T., Matsuoka M., Kenri T., Arakawa Y., Sasaki T. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 2006, 50:709-712.
16. Waites K.B., Crabb D.M., Bing X., Duffy L.B. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob. Agents Chemother. 2003, 47:161-165.
17. Waites K.B., Crabb D.M., Duffy L.B. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas. Antimicrob. Agents Chemother. 2003, 47:39-42.
18. Wolff B.J., Thacker W.L., Schwartz S.B., Winchell J.M. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob. Agents Chemother. 2008, 52:3542-3549.
19. Xin D., Mi Z., Han X., Qin L., Li J., Wei T., Chen X., Ma S., Hou A., Li G., Shi D. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob. Agents Chemother. 2009, 53:2158-2159.
20. Yoo S.J., Kim H.B., Choi S.H., Lee S.O., Kim S.H., Hong S.B., Sung H., Kim M.N. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance. Antimicrob. Agents Chemother. 2012, 56:6393-6396.